Non-vitamin K oral anticoagulants may be best for early-stage CKD
(HealthDay)—Non-vitamin K oral anticoagulants (NOACs) have a superior benefit-risk profile to that of vitamin K antagonists (VKAs) for patients with early-stage chronic kidney disease (CKD), according to a review published ...
Jul 16, 2019
0
1